O. A. Antonova

409 total citations
30 papers, 297 citations indexed

About

O. A. Antonova is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, O. A. Antonova has authored 30 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Hematology. Recurrent topics in O. A. Antonova's work include Blood Coagulation and Thrombosis Mechanisms (6 papers), Extracellular vesicles in disease (5 papers) and Platelet Disorders and Treatments (5 papers). O. A. Antonova is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (6 papers), Extracellular vesicles in disease (5 papers) and Platelet Disorders and Treatments (5 papers). O. A. Antonova collaborates with scholars based in Russia, United States and Finland. O. A. Antonova's co-authors include А. В. Мазуров, T. I. Arefieva, С. Г. Хаспекова, Boris K. Pliyev, Mikhail Menshikov, Arthur M. Melkumyants, M. Yu. Karganov, N. V. Lomakin, И. Б. Алчинова and Фазоил И. Атауллаханов and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Respiratory Journal.

In The Last Decade

O. A. Antonova

26 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. A. Antonova Russia 10 107 66 60 39 32 30 297
Lin Liao China 11 80 0.7× 68 1.0× 37 0.6× 20 0.5× 46 1.4× 22 313
Jarosław Piszcz Poland 14 95 0.9× 127 1.9× 104 1.7× 63 1.6× 74 2.3× 49 454
Goran Matic Germany 8 66 0.6× 67 1.0× 94 1.6× 58 1.5× 25 0.8× 23 330
Kathrin Schwierczek Germany 4 63 0.6× 91 1.4× 134 2.2× 33 0.8× 20 0.6× 5 345
Courtney E. Leik United States 8 93 0.9× 113 1.7× 82 1.4× 36 0.9× 42 1.3× 9 430
Iván Parra‐Izquierdo United States 11 90 0.8× 65 1.0× 77 1.3× 66 1.7× 25 0.8× 18 335
Begoña Hurtado Spain 10 89 0.8× 173 2.6× 127 2.1× 24 0.6× 18 0.6× 19 404
Tomokazu Ikemoto Japan 11 116 1.1× 47 0.7× 24 0.4× 56 1.4× 36 1.1× 22 321
Carmen van der Zwaan Netherlands 14 109 1.0× 76 1.2× 258 4.3× 48 1.2× 22 0.7× 29 459
Hongxiang Xie China 14 101 0.9× 158 2.4× 66 1.1× 24 0.6× 23 0.7× 21 425

Countries citing papers authored by O. A. Antonova

Since Specialization
Citations

This map shows the geographic impact of O. A. Antonova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. A. Antonova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. A. Antonova more than expected).

Fields of papers citing papers by O. A. Antonova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. A. Antonova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. A. Antonova. The network helps show where O. A. Antonova may publish in the future.

Co-authorship network of co-authors of O. A. Antonova

This figure shows the co-authorship network connecting the top 25 collaborators of O. A. Antonova. A scholar is included among the top collaborators of O. A. Antonova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. A. Antonova. O. A. Antonova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vorotnikov, Alexander V., O. A. Antonova, Ekaterina А. Shestakova, et al.. (2024). Shear Stress and the AMP-Activated Protein Kinase Independently Protect the Vascular Endothelium from Palmitate Lipotoxicity. Biomedicines. 12(2). 339–339. 3 indexed citations
2.
Dobrovolsky, A. B., et al.. (2023). Effects of Antiplatelet Drugs on Platelet-Dependent Coagulation Reactions. Biomolecules. 13(7). 1124–1124. 3 indexed citations
3.
Antonova, O. A., et al.. (2023). Long-Term Experimental Hyperglycemia Does Not Impair Macrovascular Endothelial Barrier Integrity and Function in vitro. Biochemistry (Moscow). 88(8). 1126–1138. 3 indexed citations
5.
Ланкин, В. З., М. Г. Шарапов, А. К. Тихазе, et al.. (2023). Dicarbonyl-Modified Low-Density Lipoproteins Are Key Inducers of LOX-1 and NOX1 Gene Expression in the Cultured Human Umbilical Vein Endotheliocytes. Biochemistry (Moscow). 88(12-13). 2125–2136. 1 indexed citations
6.
Dobrovolsky, A. B., et al.. (2022). Effects of platelets activated by different agonists on fibrin formation and thrombin generation. Platelets. 34(1). 2139365–2139365. 4 indexed citations
7.
Melkumyants, Arthur M., et al.. (2021). Injury of vascular endothelium and erythrocytes in COVID-19 patients. Consilium Medicum. 23(6). 469–476. 8 indexed citations
8.
Melkumyants, Arthur M., et al.. (2021). Mild COVID-19 and Impaired Blood Cell–Endothelial Crosstalk: Considering Long-Term Use of Antithrombotics?. Thrombosis and Haemostasis. 122(1). 123–130. 15 indexed citations
10.
Шарапов, М. Г., et al.. (2016). Enzymatic antioxidant system of endotheliocytes. Doklady Biochemistry and Biophysics. 471(1). 410–412. 17 indexed citations
11.
Antonova, O. A., et al.. (2016). Differential procoagulant activity of microparticles derived from monocytes, granulocytes, platelets and endothelial cells. Blood Coagulation & Fibrinolysis. 28(5). 373–382. 30 indexed citations
12.
Хаспекова, С. Г., et al.. (2016). Activity of tissue factor in microparticles produced in vitro by endothelial cells, monocytes, granulocytes, and platelets. Biochemistry (Moscow). 81(2). 114–121. 23 indexed citations
13.
Antonova, O. A., et al.. (2014). Pneumococcal pneumonia frequency in adult patients at three Russian Regions. European Respiratory Journal. 44(Suppl 58). P1057–P1057. 1 indexed citations
14.
Antonova, O. A., et al.. (2014). Malonyldialdehyde and glyoxal act differently on low-density lipoproteins and endotheliocytes. Molecular and Cellular Biochemistry. 396(1-2). 79–85. 11 indexed citations
15.
Antonova, O. A., et al.. (2013). Pneumococcal pneumonia frequency in therapeutic adult inpatients at three Russian Regions. PULMONOLOGIYA. 29–36. 7 indexed citations
16.
Kakorin, I., et al.. (2010). [Effect of malondialdehyde on deformability of human umbilical vein endothelial cells].. PubMed. 96(2). 147–53. 1 indexed citations
17.
Antonova, O. A., et al.. (2009). Activation and damage of endothelial cells upon hypoxia/reoxygenation. Effect of extracellular pH. Biochemistry (Moscow). 74(6). 605–612. 12 indexed citations
18.
Arefieva, T. I., et al.. (2005). MCP-1-stimulated chemotaxis of monocytic and endothelial cells is dependent on activation of different signaling cascades. Cytokine. 31(6). 439–446. 64 indexed citations
19.
Мазуров, А. В., O. A. Antonova, Tatiana V. Byzova, et al.. (2002). Safety, inhibition of platelet aggregation and pharmacokinetics of F(ab′) 2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty. Platelets. 13(8). 465–477. 18 indexed citations
20.
Mkrtumyan, А. M., et al.. (2000). Metabolic syndrome and the state of secondary immunodeficiency. Problems of Endocrinology. 46(4). 10–14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026